查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1779102

植物性 API 市場－全球產業規模、佔有率、趨勢、機會及預測，依分子類型、最終用戶、地區及競爭情況細分，2020-2030 年預測

Plant Based API Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Molecule Type, By End User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球植物性API市場價值為314億美元，預計到2030年將達到445.2億美元，複合年成長率為5.95%。全球植物性API市場正在經歷大幅成長，其關鍵促進因素包括技術創新、消費者驅動型醫療保健需求的不斷成長、慢性病發病率的上升以及對預防保健的日益重視。從血液檢測和懷孕試劑盒到血糖儀和過敏測試解決方案，植物性API產品正逐漸成為個人管理自身健康的不可或缺的工具。這些設備使用戶能夠獨立監測各種健康參數，無需就診，並幫助消費者掌控自己的健康。

市場概覽
預測期 2026-2030
2024年市場規模 314億美元
2030年市場規模 445.2億美元
2025-2030 年複合年成長率 5.95%
成長最快的領域 製藥
最大的市場 北美洲

由於診斷技術的進步、消費者健康意識的提升以及人們向更經濟實惠、更便捷、更個性化的健康解決方案的轉變，市場的成長軌跡依然強勁。隨著這些植物性API產品在健康管理策略中日益重要，預計市場將持續擴張。監管支援和診斷領域的持續創新進一步提升了市場潛力，使植物性API細分市場成為醫療保健和診斷行業利益相關者的豐厚機會。

關鍵市場促進因素

天然和有機產品需求不斷成長

主要市場挑戰

監理複雜性和缺乏統一標準

最迫切的挑戰之一是全球市場缺乏針對植物 API 的標準化和統一的監管框架。

這種分散的監管環境為投資者和開發商帶來了不確定性，減緩了研發和國際擴張的速度。

主要市場趨勢

將植物藥納入主流藥物研發

這一趨勢標誌著製藥創新的範式轉變，基於自然的 API 不再是邊緣，而是在現代治療中佔據戰略地位。

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：植物性API市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依分子類型（生物鹼、花青素、黃酮化合物、酚酸、萜類化合物、木質素和耆類化合物等）
    • 依最終使用者（藥品、保健品、草藥產業、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美植物性API市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲植物性API市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太植物性 API 市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲植物性API市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲植物性 API 市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球植物性 API 市場：SWOT 分析

第 14 章：競爭格局

  • Roquette Freres.
  • Arboris, LLC
  • Centroflora Group
  • BASF SE
  • Kothari Phytochemicals International
  • Evonik Industries AG
  • Brains
  • Indo Phytochem Pharmaceuticals
  • HimPharm.com
  • Cargill, Incorporated

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 14866

Global Plant Based API market was valued at USD 31.40 Billion in 2024 and is expected to reach USD 44.52 Billion by 2030 with a CAGR of 5.95%. The global Plant Based API market is undergoing substantial growth, fueled by key drivers such as technological innovation, increasing demand for consumer-driven healthcare, the rising incidence of chronic diseases, and a growing focus on preventive care. Plant Based API products ranging from blood tests and pregnancy kits to glucose monitors and allergy testing solutions are progressively becoming integral tools for individuals managing their own health. These devices enable users to monitor a variety of health parameters independently, eliminating the need for clinical visits and empowering consumers to take control of their health.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 31.40 Billion
Market Size 2030USD 44.52 Billion
CAGR 2025-20305.95%
Fastest Growing SegmentPharmaceuticals
Largest MarketNorth America

The market's growth trajectory remains robust, underpinned by advancements in diagnostic technologies, heightened consumer health consciousness, and a shift toward more affordable, accessible, and personalized health solutions. As these Plant Based API products become increasingly central to health management strategies, the market is expected to continue expanding. Regulatory support and ongoing innovations in diagnostics further enhance the market's potential, positioning the Plant Based API segment as a lucrative opportunity for stakeholders in the healthcare and diagnostics industries.

Key Market Drivers

Rising Demand for Natural and Organic Products

The surge in global demand for natural and organic products is a powerful and influential factor driving the growth of the plant-based active pharmaceutical ingredient (API) market. Sales of natural and organic products have demonstrated consistent upward momentum, with select categories showing exceptional performance. Notably, natural organic meat, fish, and poultry recorded a 13.1% year-over-year growth in 2024, while the organic dairy segment posted a 9.8% increase during the same period. These figures reflect a significant shift in consumer purchasing behavior, underscoring a strong preference for clean-label, sustainably sourced food products within high-consumption categories. Today's consumers are increasingly informed and health conscious. There is a marked preference for products perceived as "clean," chemical-free, and closer to nature. As a result, medications and supplements that are plant-based are seen as gentler on the body, safer for long-term use, and less likely to cause side effects. This perception fuels growing patient and consumer interest in natural-origin pharmaceuticals, creating strong demand for APIs derived from botanical sources. A recent study indicates that 80% of millennials factor in health benefits when making food choices, compared to 64% of baby boomers (individuals born between 1946 and 1964). Importantly, millennials evaluate health not only through the lens of physical wellness but also consider emotional and social well-being as integral to their dietary decisions highlighting a broader, more holistic approach to nutrition among this demographic. The global healthcare narrative is gradually moving away from reactive treatment toward preventive care and holistic wellness. Plant-based products, often associated with traditional healing systems and holistic health, are viewed as ideal for preventive care. Consequently, pharmaceutical companies are under increasing pressure to develop formulations that align with wellness trends, further pushing demand for plant-based APIs in both prescription and over-the-counter segments.

Key Market Challenges

Regulatory Complexity and Lack of Harmonized Standards

One of the most pressing challenges is the lack of standardized and harmonized regulatory frameworks for plant-based APIs across global markets.

Plant-based APIs are often categorized differently across regions ranging from herbal medicines to dietary supplements or even traditional remedies. This inconsistency complicates product registration, labeling, and market entry, particularly in regulated markets such as the U.S., EU, and Japan. Unlike synthetic APIs, which follow well-defined approval pathways, plant-based APIs require complex documentation of botanical origin, bioactive compound consistency, and clinical efficacy, which can vary depending on the source and preparation method. Complying with multiple sets of regulatory standards increases time-to-market and operational costs, particularly for SMEs and regional manufacturers attempting to scale globally.

This fragmented regulatory environment creates uncertainty for investors and developers, slowing R&D and international expansion.

Key Market Trends

Integration of Phytopharmaceuticals into Mainstream Drug Development

A significant trend reshaping the plant-based API market is the growing integration of phytopharmaceuticals into conventional drug pipelines. Historically, plant-based compounds were largely confined to traditional medicine or nutraceutical applications. However, this is changing as pharmaceutical companies recognize their potential for targeted therapeutic action with fewer side effects.

A rising number of plant-derived compounds are undergoing clinical trials, validating their efficacy for chronic and lifestyle-related diseases such as diabetes, cardiovascular disorders, cancer, and neurodegenerative conditions. Major pharmaceutical firms are partnering with biotech startups and research institutes to co-develop plant-based drugs leveraging natural product libraries for lead discovery and screening. Advances in extraction, purification, and delivery systems have allowed for the development of proprietary formulations, making plant-based APIs commercially attractive due to stronger IP protections and differentiated value propositions.

This trend signifies a paradigm shift in pharma innovation, where nature-based APIs are no longer peripheral but are being strategically positioned within modern therapeutics.

Key Market Players

  • Roquette Freres.
  • Arboris, LLC
  • Centroflora Group
  • BASF SE
  • Kothari Phytochemicals International
  • Evonik Industries AG
  • Brains
  • Indo Phytochem Pharmaceuticals
  • HimPharm.com
  • Cargill, Incorporated

Report Scope:

In this report, the Global Plant Based API Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Plant Based API Market, By Molecule Type:

  • Alkaloids
  • Anthocyanin
  • Flavonoids
  • Phenolic Acids
  • Terpenoids
  • Lignin & Stilbenes
  • Others

Plant Based API Market, By End User:

  • Pharmaceuticals
  • Nutraceuticals
  • Herbal Based Industries
  • Others

Plant Based API Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Plant Based API Market.

Available Customizations:

Global Plant Based API market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Plant Based API Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Molecule Type (Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes, Others)
    • 5.2.2. By End User (Pharmaceuticals, Nutraceuticals, Herbal Based Industries, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Plant Based API Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Molecule
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Plant Based API Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Molecule
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Plant Based API Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Molecule
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Plant Based API Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Molecule
        • 6.3.3.2.2. By End User

7. Europe Plant Based API Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Molecule
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Plant Based API Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Molecule
        • 7.3.1.2.2. By End User
    • 7.3.2. United Kingdom Plant Based API Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Molecule
        • 7.3.2.2.2. By End User
    • 7.3.3. Italy Plant Based API Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Molecule
        • 7.3.3.2.2. By End User
    • 7.3.4. France Plant Based API Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Molecule
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Plant Based API Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Molecule
        • 7.3.5.2.2. By End User

8. Asia-Pacific Plant Based API Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Molecule
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Plant Based API Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Molecule
        • 8.3.1.2.2. By End User
    • 8.3.2. India Plant Based API Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Molecule
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Plant Based API Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Molecule
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Plant Based API Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Molecule
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Plant Based API Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Molecule
        • 8.3.5.2.2. By End User

9. South America Plant Based API Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Molecule
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Plant Based API Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Molecule
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Plant Based API Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Molecule
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Plant Based API Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Molecule
        • 9.3.3.2.2. By End User

10. Middle East and Africa Plant Based API Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Molecule
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Plant Based API Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Molecule
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Plant Based API Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Molecule
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Plant Based API Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Molecule
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Plant Based API Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Roquette Freres.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Arboris, LLC
  • 14.3. Centroflora Group
  • 14.4. BASF SE
  • 14.5. Kothari Phytochemicals International
  • 14.6. Evonik Industries AG
  • 14.7. Brains
  • 14.8. Indo Phytochem Pharmaceuticals
  • 14.9. HimPharm.com
  • 14.10.Cargill, Incorporated

15. Strategic Recommendations

16. About Us & Disclaimer